English | 简体中文 | 繁體中文 | 한국어 | 日本語
2023年5月2日 19時00分
Share:
    

Source: Envision Pharma Group
Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics

PHILADELPHIA, PA, 2023年5月2日 - (亞太商訊) - Envision Pharma Group (Envision) has appointed Mike Glover to Senior Vice President, Payer and HTA Solutions. Mike will be responsible for leading and developing Envision's distinctive market access and HTA strategies for early-stage and late-stage businesses, combining customer insights, vision, and creativity. Mike's key focus areas will be transformations in patient access, global pricing strategies, real-world evidence, and improving patient outcomes.

Meg Heim, CEO of Envision Pharma Group, shares, "I am excited to welcome Mike to the team at Envision as Senior Vice President, Payer and HTA solutions. As we continue to accelerate Envision's business expansion, mission, and commitment to our clients' needs. Mike's extensive experience in developing and executing cutting-edge access, policy, and pricing strategies while executing fully integrated market access programs will be critical in partnering with our clients to execute upon their goals, improve performance, and meet their unique business needs with the support of our technology platforms."

Prior to joining Envision, Mike served as Vice President, Head of Global Access and Pricing Strategy for GlaxoSmithKline. Before that, he held various leadership positions of increasing responsibilities at GSK, Sanofi, and Bristol Myers Squibb. He brings with him a diverse background across multiple geographies, functions, and therapeutic areas. His global commercial leadership experiences spanning oncology, cardiovascular, diabetes, and virology from asset development to in-market delivery will be a valuable asset to Envision.

Mike adds, "The energy and passion of the Envision team shines through in every interaction I've had. It was this passion and desire to be the very best at what they do that made this an easy decision for me to join Envision. Our industry is facing a changing and challenging environment and Envision is building an organization that will not just deliver, but will become a true partner for our customers adding real value across the life cycle of a brand. I am delighted to be joining them at this important time in our industry's future."

About Envision Pharma Group

Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.

Contact Information:
Colleen Carter
Associate Director, Communications, Office of the CEO
colleen.carter@envisionpharma.com
1 (508) 505 8856

SOURCE: Envision Pharma Group

Topic: Press release summary
Source: Envision Pharma Group

Sectors: BioTech, Healthcare & Pharm, HR
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Envision Pharma Group Related News
Jan 18, 2024 20:00 HKT/SGT
Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer
Jan 16, 2024 20:00 HKT/SGT
Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC)
Nov 15, 2023 20:00 HKT/SGT
Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
June 15, 2023 19:00 HKT/SGT
OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
May 10, 2023 14:00 HKT/SGT
Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575